Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Debt / NOTE 3.750% 2/0
-
Number of holders
-
24
-
Total 13F principal, excl. options
-
335,633,000
-
Principal change
-
-258,000
-
Total reported value, excl. options
-
$421,453,059
-
Value change
-
+$1,958,066
-
Number of buys
-
10
-
Number of sells
-
-13
-
Price
-
$1.25
Significant Holders of NOVAVAX INC - NOTE 3.750% 2/0 as of Q4 2020
31 filings reported holding 670002AB0 - NOVAVAX INC - NOTE 3.750% 2/0 as of Q4 2020.
NOVAVAX INC - NOTE 3.750% 2/0 has 24 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $335,633,000 of principal
.
Largest 10 bondholders include Davidson Kempner Capital Management LP ($54,500,000 of principal), Whitebox Advisors LLC ($54,184,000 of principal), Graham Capital Management, L.P. ($47,936,000 of principal), PFM Health Sciences, LP ($34,000,000 of principal), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ($25,000,000 of principal), LAZARD ASSET MANAGEMENT LLC ($19,368,000 of principal), FMR LLC ($19,130,000 of principal), CITADEL ADVISORS LLC ($18,362,000 of principal), AMERIPRISE FINANCIAL INC ($17,200,000 of principal), and UBS ASSET MANAGEMENT AMERICAS INC ($10,000,000 of principal).
This table shows the top 24 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.